Skip to content

Statistics on 2017/18 Vaccination Programmes/Schemes

Statistics on 2017/18 Vaccination Programmes/Schemes

2018-02-20

Statistics on Government Vaccination Programme (as at 11 Feb 2018)

Total no. of doses administered

Categories

Seasonal Influenza Vaccine

Pneumococcal Vaccine

No. of doses administered

457,900

64,300

 
 
Statistics on Vaccination Subsidy Schemes (as at 11 Feb 2018)

Total no. of doses administered* 

Categories

Seasonal Influenza Vaccine

Pneumococcal Vaccine

No. of doses administered 310,200 29,700
 
*Based on the no. of claim reimbursement submitted by private doctors through eHealth System (Subsidies)
 


Background Information on Adverse Events following seasonal influenza vaccination

1. The 2017/18 seasonal influenza vaccine contains A/Michigan/45/2015 (H1N1) pdm09-like virus, A/Hong Kong/4801/2014 (H3N2)-like virus and B/Brisbane/60/2008-like virus antigens.  If quadrivalent influenza vaccine is being used, it shall contain the above three viruses and B/Phuket/3073/2013-like virus.

2. Seasonal influenza vaccine is very safe and usually well tolerated apart from occasional soreness, redness or swelling at the injection site (inactivated vaccine).  Some recipients may experience fever, muscle and joint pains, and tiredness beginning 6 to 12 hours after vaccination and lasting up to two days. 

3. An adverse event is a health problem that is reported after someone gets vaccinated. It may or may not have been caused by the vaccine.  Some of these events may occur by chance during the post-vaccination period and are unrelated to vaccination. Report of adverse event does not mean that a vaccine caused the event.

Number of GBS (within the period of 5 days and 6 weeks after vaccination) and other serious neurological adverse events reported among vaccinated person in 2017/18 season (as of 12 noon, 12 Feb 2018):

Guillain-Barré Syndrome
Other serious neurological adverse events
0
0

For the number of newly admitted GBS cases in Hong Kong, please click here.